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IntroductIon
Coronary artery disease (CAD; also known as atherosclerotic heart disease) is the most common type of heart disease and a frequent cause of cardiac events. [1] An Indian shrub known as Arjuna has been used mainly in ayurvedic medicine to support cardiovascular health. [2] Extract of this plant contains variety of flavonoids and polyphenols, which help to reduce inflammation that causes plaque formation in arteries. [3] The extract also supports healthy lipid profile. [4] Oligomeric proanthocyanidins and flavonoids present in Terminalia arjuna extract boost the natural antioxidant defence system of the heart and strengthen the vascular system of the body. It might prevent atherothrombosis by inhibiting platelet aggregation in CAD patients. [5, 6] It helps to treat angina, lower the blood pressure, to treat in congestive heart failure and improves lipid profile and prevents atherosclerosis. In a small clinical trial, it was found that frequency and severity of angina could be reduced and onset could be delayed with the use of Arjuna. In people with mild angina, changes in the heart muscles owing to ischaemia might be reversed by taking the herb. [7, 8] Arjuna bark powder taken along with vasodilator and diuretics improves the symptoms of heart failure. [9] Findings in the animal studies show that therapy with Arjuna bark reduces total cholesterol, low-density lipoprotein (LDL) and triglycerides and increases high-density lipoprotein (HDL) or good cholesterol in blood. [10] In a study, it was found that the rabbits receiving T. arjuna had a marked reduction in total cholesterol than control rabbits. [11] Arjuna bark powder could protect the heart from adverse effect of chronic high blood pressure by lowering the systolic blood pressure levels. The herb might help to boost cardiovascular endurance. [12] Keeping in mind all these medicinal use of T. arjuna, we decided to study the effect of herb on total platelet count, lipid profile and other clinical parameters in patients of CAD.
MaterIals and Methods
One hundred patients were selected from the patients attending Haldiram Moolchand Government Centre for cardiovascular research and Mohta Rasayanshala, Bikaner. The study was conducted at Department of Physiology, Sardar Patel Medical College, Bikaner. Approval from the institutional ethical committee was taken for the study. Selected patients were randomised to two groups of 50 patients no.ad/ec 18 as study and control group. Baseline parameters such as pulse rate, body weight, blood pressure, total platelet count and lipid profile were obtained from the patient of both groups after detailed history taking and general physical examination. Patients of the study group were asked to take 3 g of Arjuna Chhal Powder mixed in 250 ml of milk heated till it is boiling, twice daily for a period of 1 month. Both the groups were evaluated after 1 month for all the baseline parameters [ Table 1 ].
Exclusion criteria
Patient suffering from liver disease, arthritis, asthma, pulmonary tuberculosis, malabsorption and patient not giving consent.
Patients were examined for: 
Statistical analysis
For statistical comparison of data, appropriate model was applied and the results with P < 0.05 were considered significant. Since the study was conducted at one place, only geographical and climatic condition remained unchanged. The data are expressed as mean ± standard deviation.
results
The body weight in study group decreased slightly from 79.40 ± 7.63 to 79. Table 2 ]. Baseline data of both the study and control groups were matched.
dIscussIon
Arjuna has been a part of Ayurveda since 2500 BC as a heart tonic. It is used to treat cardiovascular disease including angina pectoris, ischaemic heart disease, cardiomyopathy and congestive heart failure and act as cardioprotective agent in hypertension.
In the present study, it was found that use of T. arjuna is beneficial in patient of CAD. A report published in journal of research in education in Indian medicine (1988) has stated Arjuna to be possessing antihypertensive, cardiotonic and diuretic properties. It has been shown to increase the HDL-C levels. Indian Medical Gazette (1998) has stated that Arjuna bark extract in dose of 500 mg with other drug given for 3 months improves treadmill test and exercise tolerance considerably without any side effects in angina pectoris. It was observed that aortic prostaglandin E 2 (PGE2)-like activity was enhanced after administration of T. arjuna. PGE2 is known to produce coronary vasodilation and increased coronary flow in patients of CAD. [12] In a 1995 double-blind study in the international journal of cardiology, patients who had taken Arjuna for 2 weeks experienced a 19% lower heart rate than those who took a placebo. Symptoms such as fatigue, high blood pressure, heart rate and frequent contractions also improved. [13] In our study, we found that systolic and diastolic blood pressure decreased after 1 month of T. arjuna therapy. The extract of T. arjuna might contain active compound possessing adrenergic β 2 receptor agonistic action and/or direct action on the heart. [14] One month of treatment of 500 mg/kg Arjuna bark powder extract to normal and diabetic rats, reflex bradycardia was improved in diabetic rats. The alteration in reflex tachycardia was not improved by Arjuna over 30 days. [15] Sandhu JS and Shah B stated that Arjuna bark powder could protect the heart from the adverse effect of chronic high blood pressure by lowering the systolic blood pressure levels and our results are in close conformity in their statement.
In the present study, whole lipid profile changed favourably after 1 month therapy of T. arjuna. Dwivedi reports that a study described in a thesis by S. Khalil in 2005 found that Arjuna bark powder along with statin for 3 months resulted in a 15% decrease in total cholesterol, 11% decrease in serum triglyceride level and 16% decrease in LDL cholesterol. There was a minimal decline in lipoprotein and nitrite levels. The result suggests that Arjuna may work synergistically with statin in hyperlipidaemia. [16] The cardioprotective effects of Arjuna are partly related to its antioxidant activities, and several studies have shown that Arjuna protects the heart against myocardial ischaemic reperfusion injury. [17] [18] [19] Arjunolic acid has furthermore been shown to prevent the decrease in the levels of superoxide dismutase, catalase, glutathione peroxidase, ceruloplasmin, alpha-tocopherol, glutathione (GSH), ascorbic acid, lipid peroxide and myeloperoxidase in experimental myocardial necrosis in rats and to restore the electrocardiographic changes towards normalcy. [20] More recently, arjuna has been shown to enhance the cardiac intracellular antioxidant activity. Histological studies also supported the protective role of arjuna. [21] On the evaluation at the end of 3 months therapy with bark of T. arjuna, it was found that treadmill test grading of positivity was reduced significantly and exercise tolerance of patients increased. [22] conclusIons It can be concluded that in patients of CAD, T. arjuna can significantly reduce blood pressure and favourably modify lipid profile. It might also have antioxidant properties and may be beneficial for cardiac as well as overall health.
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